<--- Back to Details
First PageDocument Content
Medicine / Pharmaceuticals policy / Food and Drug Administration / Clinical pharmacology / Drugs / Prescription Drug User Fee Act / Biosimilar / Prescription medication / Pharmacy / Pharmaceutical sciences / Health / Pharmacology
Medicine
Pharmaceuticals policy
Food and Drug Administration
Clinical pharmacology
Drugs
Prescription Drug User Fee Act
Biosimilar
Prescription medication
Pharmacy
Pharmaceutical sciences
Health
Pharmacology

FY 2015 FDA Operating Plan

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 569,60 KB

Share Document on Facebook

Similar Documents

Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT

DocID: 1t0K4 - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1 Basic PDUFA Construct

DocID: 1sUEh - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016 Page 1 1 FOOD AND DRUG ADMINISTRATION (FDA)

DocID: 1sUz3 - View Document

Health / Pharmaceutical sciences / Pharmaceutical industry / Food and Drug Administration / Advertising / Direct-to-consumer advertising / Unnecessary health care / Prescription Drug User Fee Act / Criticism of the Food and Drug Administration

United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight

DocID: 1rfHg - View Document

Health / Pharmaceuticals policy / Food and Drug Administration / Medical research / Names / Healthcare quality / Patient safety / United States Adopted Name / Prescription Drug User Fee Act / Over-the-counter drug / Medical prescription / International nonproprietary name

Best Practices in Developing Proprietary Names for Drugs

DocID: 1r8R5 - View Document